February 5, 2020 / 1:26 PM / in 20 days

BRIEF-Nestlé Health Science Announces $200 Mln Investment In Aimmune Therapeutics

Feb 5 (Reuters) - Nestle SA:

* NESTLÉ HEALTH SCIENCE FURTHER INVESTS IN AIMMUNE THERAPEUTICS

* WILL MAKE A FURTHER EQUITY INVESTMENT OF USD 200 MILLION IN AIMMUNE THERAPEUTICS Source text: bit.ly/381zmyC Further company coverage: (Berlin Speed Desk)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below